Medical Profiles

Massachusetts
General Hospital
Dermatology Laser
and Cosmetic Center

50 Staniford Street, Suite 250
Boston | 617.724.6960

Massachusetts General Hospital Dermatology Laser and Cosmetic Cente's depth of experience is unmatched. Only our board certified dermatologists with extensive laser and cosmetic training perform the treatments, allowing the center to offer top quality services while ensuring patient's safety and satisfaction. No other center in Boston offers the extensive list of services available at Mass General with the expertise of renowned Mass General physicians. It is the cutting-edge center where many of today's most advanced techniques were invented or developed, and continues to lead the way. The Mass General Laser and Cosmetic Center trained many of America's top cosmetic dermatologists, and continues to work closely with the industry, inventing and designing the newest, most-effective, and science-driven devices and technologies.

In collaboration with the Wellman Center for Photomedicine, we continue to make major contributions in innovative technologies from developing the theory behind non-scarring laser surgery and fractional resurfacing, to CoolSculpting™, the latest body contouring technique. From inception, our physicians are actively involved in the development of new technologies, earning them the reputation as international leaders in our field, and the place where other dermatologists often turn with clinical questions.

The Dermatology Laser and Cosmetic Center provides a full range of services in a state-of-the art suite. Each patient's condition is carefully evaluated and the best laser (or lasers) is chosen to ensure optimal outcome, some of which are listed below.

- Laser Hair Removal*
- Tattoo Removal*
- Pulsed-dye treatments for Rosacea*
- Fraxel® (Fractional Laser Resurfacing) *
- Body Contouring (including CoolSculpting™ by Zeltiq™)*
- Botox®
- Soft Tissue Fillers (Restylane®, Juvéderm®, Radiesse®, Perlane®)
- Chemical Peels
- Acne and Acne Scars
- Brown Spots and Sun Damage
*bold indicates technologies developed at Mass General

Many treatments are available with little or no down-time, allowing patients to return to their lives almost immediately. The Clinical Studies Unit of Boston University Psychiatry Associates, Inc is directed by Domenic A. Ciraulo M.D., Professor and Chairman, Department of Psychiatry at Boston University Medical School and Psychiatrist-in-Chief at Boston Medical Center. He is board certified by the American Board of Psychiatry and Neurology with added qualifications in addiction psychiatry. He is a distinguished fellow of the American Psychiatry Association and has served on its council on addictions. Dr. Ciraulo is a member of the American Medical Association, the Massachusetts Medical Society, the Massachusetts Psychiatric Society, and the Research Society on Alcoholism. He has been listed in Best Doctors since 1992, named by the Consumer Research Council of America as one of "America's Top Psychiatrists," and by Town and Country Magazine as a "Best Medical Specialist" in North America. He serves as study chair for the National Institute on Alcohol Abuse and Alcoholism's National Clinical Investigation Group for medication studies in alcoholism. His research is highly regarded and published in leading medical journals, including the Journal of the American Medical Association (JAMA). He is the editor of several medical textbooks, including Clinical Manual of Chemical Dependence, Clinical Manual of Addiction Psychopharmacology, Pharmacotherapy of Depression, and Drug Interactions in Psychiatry. In addition to his research publications and monographs, he has contributed over 50 chapters to textbooks in the field.

Under his leadership, the Clinical Studies Unit has specialized in developing novel therapies for alcoholism, stimulant dependence, and prescription drug abuse. Current research interests of the CSU include medications that reduce the desire to drink alcohol; the use of transcranial magnetic stimulation for the treatment of depression, alcoholism and addiction; and the use of genetic markers and brain imaging to discover factors that contribute to successful treatment.hicago-based Accreditation Association for Ambulatory Health Care, Inc. (AAAHC) since 1998.